Addiction Treatment Within U.S. Correctional Facilities: Bridging the Gap Between Current Practice and Evidence-Based Care

REFERENCES

• Pew Center on the States. One in 100: behind bars in America, 2008. Retrieved October 23, 2014, from http://www.pewcenteronthestates.org/uploadedFiles/8015PCTS_Prison08_FINAL_2-1-1_FORWEB.pdf.
   Google Scholar
• Bewley-Taylor D, Hallam C, Allen R. The incarceration of drug offenders: an overview. Report sixteen. The Beckley Foundation Drug Policy Programme, 2009. http://www.beckleyfoundation.org/pdf/BF_Report_16.pdf
   Google Scholar
• Mumola CJ, Karberg JC. Drug use and dependence, state and federal prisoners. Bureau of Justice Statistics, October 2006, NCJ 213530, 2004.
   Google Scholar
• NIDA. Principles of drug addiction treatment. National Institutes of Health, 2012.
   Google Scholar
• Bruce RD, Smith-Rohrburg D, Altice FL. Pharmacological treatment of substance abuse in correctional facilities; prospects and barriers to expanding access to evidence-based therapy. In Greifenger R, ed. Public health behind bars; from prisons to communities. New York, NY: Springer, 2007:385–411.
   Google Scholar
• Allen SA, Wakeman SE, Cohen RL, Rich JD. Physicians in US prisons in the era of mass incarceration. Int J Prison Health 2010; 6(3):100–6.
   PubMedGoogle Scholar
• Binswanger IA, Stern MF, Deyo RA, et al. Release from prison—a high risk of death for former inmates. N Engl J Med 2007; 356:157–65.
   PubMed Web of Science ®Google Scholar
• Magura S, Lee JD, Hershberger J, et al. Buprenorphine and methadone maintenance in jail and post-release: a radomized clinical trial. Drug Alcohol Depend 2009; 99(1–3):222–30.
   PubMed Web of Science ®Google Scholar
• Dole VP. Detoxification of sick addicts in prison. JAMA. 1972; 220(3):366–9.
   PubMed Web of Science ®Google Scholar
• Fiscella K, Pless N, Meldrum S, Fiscella P. Alcohol and opiate withdrawal in US jails. Am J Public Health 2004; 94:1522–4.
   PubMed Web of Science ®Google Scholar
• Oser CB, Knudsen HK, Staton-Tindall M, Tasman F, Leukefeld C. Organizational-level correlates of the provision of detoxification services and medication-based treatments for substance abuse in correctional institutions. Drug Alcohol Depend 2009; 103(1):S73–81.
   PubMed Web of Science ®Google Scholar
• Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev 2003; (2):CD002209.
   Google Scholar
• Carrieri MP, Amass L, Lucas GM, Vlahov D, Wodak A, Woody GE. Buprenorphine use: the international experience. Clin Infect Dis 2006; 43(4):S197–215.
   PubMed Web of Science ®Google Scholar
• UNODC-UNAIDS-WHO framework for HIV AIDS prevention, treatment, and care in prison, 2006. https://www.unodc.org/pdf/HIV-AIDS_prisons_July06.pdf (accessed January, 21, 2014).
   Google Scholar
• Pecoraro A, Woody GE. Medication-assisted treatment for opioid dependence: making a difference in prisons. F1000 Medicine Reports 2011, 3:1.
   Google Scholar
• Tomasino V, Swanson AJ, Nolan J, Shuman HI. The Key Extended Entry Program (KEEP): a methadone treatment program for opiate-dependent inmates. Mt Sinai J Med 2001; 68(1):14–20.
   PubMed Web of Science ®Google Scholar
• Rich JD, Boutwell AE, Shield DC, et al. Attitudes and practices regarding the use of methadone in US state and federal prisons. J Urban Health 2005; 82(3):411–9.
   PubMed Web of Science ®Google Scholar
• Gordon MS, Kinlock TW, Schhwartz RP, O'Grady KE. A randomized clinical trial of methadone maintenance for prisoners: findings at 6 months post-release. Addiction 2008; 103(8):1333–42.
   PubMed Web of Science ®Google Scholar
• McKenzie M, Zaller N, Dickman SL, et al. A randomized trial of methadone initiation prior to release from incarceration. Subst Abus 2012; 33(1):19–29.
   PubMed Web of Science ®Google Scholar
• Garcia CA, Correa GC, Viver AD, et al. Buprenorphine-naloxone treatment for pre-release opioid-dependent inmates in Puerto Rico. J Addict Med 2007; 1(3):126–32.
   PubMed Web of Science ®Google Scholar
• Dolan KA, Shearer J, MacDonald M, et al. A randomised controlled trial of methadone maintenance treatment versus wait list control in an Australian prison system. Drug Alcohol Depend 2003; 72(1):59–65.
   PubMed Web of Science ®Google Scholar
• Dolan KA, Shearer J, White B, et al. Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration, and hepatitis C infection. Addiction 2005; 100(6):820–8.
   PubMed Web of Science ®Google Scholar
• Marzo JN, Rotily M, Meroueh F, et al. Maintenance therapy and 3-year outcome of opioid-dependent prisoners: a prospective study in France (2003–2006). Addiction 2009; 104(7):1233–40.
   PubMed Web of Science ®Google Scholar
• Hedrich D, Alves P, Farrell M, et al. The effectiveness of opioid maintenance treatment in prison settings: a systematic review. Addiction 2012; 107(3):501–17.
   PubMed Web of Science ®Google Scholar
• Stallwitz A, Stöver H. The impact of substitution treatment in prisons—a literature review. Int J Drug Policy 2007; 18(6):464–74.
   PubMed Web of Science ®Google Scholar
• Coviello DM, Cornish JW, Lynch KG, et al. A multi-site pilot study of extended-release injectable naltrexone treatment for previously opioid-dependent parolees and probationers. Subst Abus 2012; 33(1):48–59.
   PubMed Web of Science ®Google Scholar
• Ginn S. Can incarceration be thought of as disease? BMJ 2012; 344:e2851.
   Web of Science ®Google Scholar
• Anderson, S. European drug policy: the cases of Portugal, Germany, and The Netherlands. EIU Political Science Review, 2012. Retrieved on October 23, 2014, from http://www.eiu.edu/˜polisci/EIU%20Political%20Science%20Review%20Vol%201%20issue%201%20article%202.pdf.
   Google Scholar
• Greenwald G. Drug decriminalization in Portugal: lessons for creating fair and successful drug policies. CATO Institute 2009. Retrieved from http://object.cato.org/sites/cato.org/files/pubs/pdf/greenwald_whitepaper.pdf.
   Google Scholar
• Uchtenhagen A. Heroin-assisted treatment in Switzerland: a case study in policy change. Addiction 2010; 105(1):29–37.
   PubMed Web of Science ®Google Scholar
• Travis J, Western B. The growth of incarceration in the United States: exploring causes and consequences. National Research Council, National Academies of Science. Washington, DC: 2014.
   Google Scholar
• Belenko, S. Research on drug courts: a critical review, 2001 update. New York: National Center on Addiction and Substance Abuse, 2001.
   Google Scholar
• Guydish J, Wolfe E, Tajima B, Woods WJ. Drug court effectiveness: a review of California evaluation reports, 1995–1999. J Psychoactive Drugs 2001; 33(4):369–78.
   PubMed Web of Science ®Google Scholar
• National Drug Court Institute. NDCI Drug Court Practitioner Fact Sheets. Methadone and other pharmacotherapeutic interventions in the treatment of opioid dependence. Alexandria, VA: National Drug Court Institute; 2002.
   Google Scholar
• Matusow H, Dickman SL, Rich JD, et al. Medication assisted treatment in US drug courts: results from a nationwide survey of availability, barriers, and attitudes. J Subst Abus Treat 2013; 44(5):473–80.
   PubMed Web of Science ®Google Scholar
• Csete J, Catania H. Methadone treatment providers' views of drug court policy and practice: a case study of New York State. Harm Reduction Journal 2013, 10:35.
   PubMed Web of Science ®Google Scholar
• Givens A, Glorioso C. I-team: father faults judge for son's heroin overdose. NBC New York. http://www.nbcnewyork.com/news/local/Methadone-Judge-Rule-Father-Blame-Lepolszki-Son-Overdose-Heroin-Addict-Ruling-I-Team-Investigation-273213211.html (accessed August, 29, 2014).
   Google Scholar